Results 211 to 220 of about 912,795 (359)

“Nature's Polymer Reimagined: Conventional and Green Routes to Pectin, Its Bioactive Promise and Industrial Applications”

open access: yesFood Chemistry International, EarlyView.
Pectin, a versatile natural polymer, is extracted through conventional and emerging green extraction methods, offering multifunctional bioactive properties useful in food, pharmaceutical, and environmental applications. ABSTRACT Pectin, a molecular tapestry woven from diverse polysaccharides, holds a pivotal role across food, pharmaceutical, and ...
Afra Anika Rafique   +3 more
wiley   +1 more source

A Pharmacogenomics‐Guided Antihypertensive Strategy for Blood Pressure Reduction in Rural China: A Cluster‐Randomized Controlled Trial

open access: yesHealth Care Science, EarlyView.
This manuscript reports the findings from the Pharmacogenomic‐guided Antihypertensive Strategy Trial study amidst the deteriorating blood pressure control observed globally during the COVID‐19 pandemic. A pharmacogenomics‐guided strategy achieved a 98.4% blood pressure control rate at 4 weeks in rural China.
Wangjun Qin   +22 more
wiley   +1 more source

The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort Study. [PDF]

open access: yesClin Epidemiol
Bollerup S   +25 more
europepmc   +1 more source

The Effects of Compulsory Licensing: A Case Study of HIV Drugs

open access: yesHealth Economics, EarlyView.
ABSTRACT Compulsory licensing is a legal mechanism that allows governments the use of patented medicines without the owner's consent, subject to conditions and compensation, to meet public‐health needs. Despite its policy relevance and increasing use, empirical evidence on its market effects remains limited.
Nicolau Martin‐Bassols   +2 more
wiley   +1 more source

Accuracy of Surveys for Estimating Coverage for Hepatitis A and B Vaccinations in Adults. [PDF]

open access: yesPrev Chronic Dis
Crane LA   +9 more
europepmc   +1 more source

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

Identification of chronic hepatitis B

open access: yesJournal of Hepatology, 2013
Lai, Shih-Wei, Liao, Kuan-Fu
openaire   +2 more sources

Chapter4 , Hepatitis B: 4 -- 1 Chapter 4: Hepatitis B

open access: yes, 2007
utralizing antibody that creates immunity from future infection. In infants, young children, and immunosuppressed persons, most newly acquired HBV infections result in chronic infection.
Lyn Finelli Dph, Hepatitis B
core  

Identification of Marine-Derived Compounds with Potent Antiviral Activity in a Recombinant HBV cccDNA Cell Model

open access: yesACS Omega
Xinluo Song   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy